Bonanad, C.; Raposeiras-Roubin, S.; GarcÃa-Blas, S.; Núñez-Gil, I.; Vergara-Uzcategui, C.; DÃez-Villanueva, P.; Bañeras, J.; BadÃa Molins, C.; Aboal, J.; Carreras, J.;
et al. Evaluation of the Use of Dual Antiplatelet Therapy beyond the First Year after Acute Coronary Syndrome. J. Clin. Med. 2022, 11, 1680.
https://doi.org/10.3390/jcm11061680
AMA Style
Bonanad C, Raposeiras-Roubin S, GarcÃa-Blas S, Núñez-Gil I, Vergara-Uzcategui C, DÃez-Villanueva P, Bañeras J, BadÃa Molins C, Aboal J, Carreras J,
et al. Evaluation of the Use of Dual Antiplatelet Therapy beyond the First Year after Acute Coronary Syndrome. Journal of Clinical Medicine. 2022; 11(6):1680.
https://doi.org/10.3390/jcm11061680
Chicago/Turabian Style
Bonanad, Clara, Sergio Raposeiras-Roubin, Sergio GarcÃa-Blas, Iván Núñez-Gil, Carlos Vergara-Uzcategui, Pablo DÃez-Villanueva, Jordi Bañeras, Clara BadÃa Molins, Jaime Aboal, Jose Carreras,
and et al. 2022. "Evaluation of the Use of Dual Antiplatelet Therapy beyond the First Year after Acute Coronary Syndrome" Journal of Clinical Medicine 11, no. 6: 1680.
https://doi.org/10.3390/jcm11061680
APA Style
Bonanad, C., Raposeiras-Roubin, S., GarcÃa-Blas, S., Núñez-Gil, I., Vergara-Uzcategui, C., DÃez-Villanueva, P., Bañeras, J., BadÃa Molins, C., Aboal, J., Carreras, J., Bodi, V., Gabaldón-Pérez, A., Mateus-Porta, G., Parada Barcia, J. A., MartÃnez-Sellés, M., Chorro, F. J., & Ariza-Solé, A.
(2022). Evaluation of the Use of Dual Antiplatelet Therapy beyond the First Year after Acute Coronary Syndrome. Journal of Clinical Medicine, 11(6), 1680.
https://doi.org/10.3390/jcm11061680
